@mangarone23 @luisamnMD @NM_IDSteward @NU_IntMed Thought provoking. Study findings c/w data on value of adjunctive testing (procalcitonin) to reduce abx exposure in a more broadly defined group of pts with acute resp illness (https://t.co/BGmg59FQ6B).
My very limited experience w/ procal aligns w/ this. It gave our team another piece of obj data that made us feel okay stopping abx in the patient our clinical judgment suggested would be safe w/o them. But it may have given a false confidence. https://t.c
@jackpenner Also, "When procalcitonin algorithms are used, the greatest reduction in antibiotic use comes from earlier antibiotic discontinuation rather than curtailing antibiotic initiation" https://t.co/zWtm8GXxfB